BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20966433)

  • 1. Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humans.
    Abel EL; Angel JM; Riggs PK; Langfield L; Lo HH; Person MD; Awasthi YC; Wang LE; Strom SS; Wei Q; DiGiovanni J
    J Natl Cancer Inst; 2010 Nov; 102(21):1663-75. PubMed ID: 20966433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor development.
    Angel JM; Abel EL; Riggs PK; McClellan SA; DiGiovanni J
    G3 (Bethesda); 2014 Apr; 4(6):1071-9. PubMed ID: 24700353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM; Caballero M; DiGiovanni J
    Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion.
    Riggs PK; Angel JM; Abel EL; DiGiovanni J
    Mol Carcinog; 2005 Oct; 44(2):122-36. PubMed ID: 16044405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Angel JM; Beltrán L; Minda K; Rupp T; DiGiovanni J
    Mol Carcinog; 1997 Oct; 20(2):162-7. PubMed ID: 9364205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
    Naito M; Chenicek KJ; Naito Y; DiGiovanni J
    Carcinogenesis; 1988 Apr; 9(4):639-45. PubMed ID: 3128409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the mapping of a 12-O-tetradecanoylphorbol-13-acetate promotion susceptibility locus, Psl1, to distal mouse chromosome 9.
    Angel JM; Caballero M; DiGiovanni J
    Mol Carcinog; 2001 Dec; 32(4):169-75. PubMed ID: 11746828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice.
    DiGiovanni J; Imamoto A; Naito M; Walker SE; Beltrán L; Chenicek KJ; Skow L
    Carcinogenesis; 1992 Apr; 13(4):525-31. PubMed ID: 1576703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Shen J; Abel EL; Riggs PK; Repass J; Hensley SC; Schroeder LJ; Temple A; Chau A; McClellan SA; Rho O; Kiguchi K; Ward MD; Semmes OJ; Person MD; Angel JM; Digiovanni J
    Carcinogenesis; 2012 Nov; 33(11):2208-19. PubMed ID: 22782996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of skin tumor promotion.
    Angel JM; DiGiovanni J
    Prog Exp Tumor Res; 1999; 35():143-57. PubMed ID: 10377758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
    Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
    Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
    Ramsay HM; Harden PN; Reece S; Smith AG; Jones PW; Strange RC; Fryer AA
    J Invest Dermatol; 2001 Aug; 117(2):251-5. PubMed ID: 11511301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of epidermal protein kinase C activity, ornithine decarboxylase induction and DNA synthesis stimulated by TPA or dioctanoylglycerol in mouse strains with differing susceptibility to TPA-induced tumor promotion.
    Mills KJ; Smart RC
    Carcinogenesis; 1989 May; 10(5):833-8. PubMed ID: 2706740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic factors controlling responsiveness to skin tumor promotion in mice.
    DiGiovanni J
    Prog Clin Biol Res; 1995; 391():195-212. PubMed ID: 8532717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A wild-derived inbred mouse strain, MSM/Ms, provides insights into novel skin tumor susceptibility genes.
    Okumura K; Saito M; Wakabayashi Y
    Exp Anim; 2021 Aug; 70(3):272-283. PubMed ID: 33776021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion.
    Zhao J; Sharma Y; Agarwal R
    Mol Carcinog; 1999 Dec; 26(4):321-33. PubMed ID: 10569809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.
    Peissel B; Zaffaroni D; Pazzaglia S; Manenti G; Zanesi N; Zedda I; Rebessi S; Covelli V; Dragani TA; Saran A
    Mamm Genome; 2001 Apr; 12(4):291-4. PubMed ID: 11309660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal ornithine decarboxylase and nuclear proto-oncogenes in phorbol ester tumor promotion-sensitive and -resistant mice.
    Kennard MD; Kang DC; Montgomery RL; Butler AP
    Mol Carcinog; 1995 Jan; 12(1):14-22. PubMed ID: 7818761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.